An ALMS1 variant disrupts proximal centriole organization and promotes a myofibroblast-like phenotype that is regulated by THY1

The human heart is a tireless pump, but its inner lining, the endocardium, must remain smooth and flexible to allow blood to flow without resistance. In a rare and severe condition known as primary endocardial fibroelastosis, this lining becomes dangerously thick and stiff, coated in a layer of elastic material that restricts the heart's ability to expand and contract. This thickening occurs without any obvious structural blockage or defect in the heart's valves or chambers, leaving doctors to wonder what triggers such a dramatic transformation of the tissue. The cells responsible for building this scar-like tissue are fibroblasts, the body's natural repair crew. When these cells become overactive, they turn into myofibroblasts, a more aggressive version that churns out excessive amounts of structural proteins, effectively cementing the heart in a state of rigidity. Understanding how a single genetic error can push these cells into overdrive is crucial, not only for solving this specific heart mystery but for grasping how our cells interpret their internal architecture to decide when to build and when to stop.

Researchers at UCLA and Washington University have now traced the roots of this condition to a specific genetic flaw in a protein called ALMS1. By studying skin cells taken from a patient suffering from primary endocardial fibroelastosis, the team discovered that the loss of this protein sets off a chain reaction that fundamentally alters the cell's behavior. The patient's cells, which should have been quiet and stable, were found to be in a state of constant activation, behaving like myofibroblasts and producing far too much of the elastic and collagenous material that clogs the heart. The study reveals that this overactive state is driven by two distinct problems: a physical breakdown in the cell's internal scaffolding and a chemical signal that tells the cell to keep building.

The investigation began by looking at the patient's cells under a microscope to see what was missing. The ALMS1 protein is normally found at the base of tiny, hair-like projections called cilia, which act as sensory antennas on the surface of cells. In the patient's cells, the researchers found that the ALMS1 protein was completely absent. Without it, the cells struggled to form these cilia, and the internal structures that hold the cell's division machinery together became disorganized. Using advanced super-resolution imaging, the scientists visualized the base of these cellular antennas in incredible detail. In healthy cells, ALMS1 forms a distinct, cap-like structure that anchors other proteins together, keeping the two halves of the cell's central organizing unit, the centriole, tightly coupled. In the patient's cells, this cap was shattered and fragmented, causing the anchoring proteins to scatter and the centrioles to drift apart. This physical disarray suggests that the cell's internal architecture is compromised, much like a building where the foundation beams have been severed.

However, the physical damage was only part of the story. The researchers also examined the chemical messages the cells were sending and receiving. They found that the patient's cells had lost a specific surface marker called THY1, a molecule that normally acts as a brake on cell activation. In healthy fibroblasts, the presence of THY1 keeps the cells from becoming overzealous builders. In the patient's cells, the absence of this brake allowed the cells to switch into a high-gear myofibroblast mode, flooding the environment with elastic proteins and other matrix components. The study confirmed that this shift was driven by a surge in a signaling pathway known to promote tissue scarring. The researchers noted that while the physical defects in the centriole and the loss of cilia were permanent features of the patient's cells, the aggressive behavior of the cells was chemically regulated by the missing THY1.

To test whether this chemical imbalance was the true driver of the disease, the scientists added a soluble form of the missing THY1 protein to the patient's cells. The result was striking: the addition of this single molecule calmed the cells down. The cells stopped producing excessive amounts of elastic proteins, their size returned to normal, and they stopped acting like aggressive myofibroblasts. Crucially, this chemical rescue did not fix the broken internal scaffolding or restore the missing cilia; the physical defects remained, but the cell's behavior was corrected. This finding suggests that the disease phenotype is not solely a result of the structural damage but is actively maintained by the lack of the THY1 signal. The study indicates that while the genetic error causes a structural collapse, it is the subsequent loss of the THY1 brake that pushes the cells into the pathological state seen in the heart.

The implications of these findings offer a new perspective on how genetic errors translate into tissue disease. The research shows that a single mutation can disrupt the physical integrity of the cell while simultaneously removing a chemical safeguard that prevents overgrowth. The fact that adding back the missing signal could reverse the aggressive behavior of the cells, even while the structural damage persisted, points to a potential therapeutic avenue. If the overproduction of scar tissue in the heart is driven by this specific chemical imbalance, then restoring the THY1 signal could potentially halt or reverse the progression of the disease. The authors suggest that targeting this pathway might provide a way to treat the fibrosis associated with this condition, moving beyond the current limitations of managing only the symptoms. By identifying the specific molecular switch that turns a normal cell into a disease-driving factory, the study provides a clear target for future interventions, offering hope that the relentless buildup of scar tissue in the heart can be stopped at its source.